509 related articles for article (PubMed ID: 7913703)
1. Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.
Fu KK; Hammond E; Pajak TF; Clery M; Doggett RL; Byhardt RW; McDonald S; Cooper JS
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):661-71. PubMed ID: 7913703
[TBL] [Abstract][Full Text] [Related]
2. P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.
Hammond E; Berkey BA; Fu KK; Trotti A; Meredith RF; Jones CU; Byhardt R; Horwitz EM; Ang KK
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):683-92. PubMed ID: 14529772
[TBL] [Abstract][Full Text] [Related]
3. Predictive value of the flow cytometric PCNA assay (proliferating cell nuclear antigen) in head and neck tumors after accelerated-hyperfractionated radiochemotherapy.
Wenz F; Lohr F; Flentje M; Rudat V; Dietz A; Wannenmacher M
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):771-6. PubMed ID: 9128950
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in advanced gastric cancers.
Kimura H; Yonemura Y; Epstein AL
Cancer; 1991 Nov; 68(10):2175-80. PubMed ID: 1913456
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric measurements of proliferation-associated nuclear antigen p105 and DNA content in non-Hodgkin's lymphomas.
Turner RR; Layfield LJ; Bishop PC; Epstein AL; Parker JW
Arch Pathol Lab Med; 1989 Aug; 113(8):907-11. PubMed ID: 2569301
[TBL] [Abstract][Full Text] [Related]
6. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric quantitation of the proliferation-associated nuclear antigen p105 and DNA content in patients with renal cell carcinoma.
Yokogi H
Cancer; 1996 Aug; 78(4):819-26. PubMed ID: 8756377
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.
Fitzgibbons PL; Turner RR; Appley AJ; Bishop PC; Nichols PW; Epstein AL; Apuzzo ML; Chandrasoma PT
Am J Clin Pathol; 1988 May; 89(5):640-4. PubMed ID: 2895977
[TBL] [Abstract][Full Text] [Related]
9. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
10. Flow cytometric analysis of pituitary tumors. Correlation of nuclear antigen p105 and DNA content with clinical behavior.
Fitzgibbons PL; Appley AJ; Turner RR; Bishop PC; Parker JW; Breeze RE; Weiss MH; Apuzzo ML
Cancer; 1988 Oct; 62(8):1556-60. PubMed ID: 3048631
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between cellular DNA contents and cell proliferation of non-small cell lung cancer estimated by simultaneous quantification of PCNA and DNA contents by flow cytometer].
Morita K; Hayashi Y; Nagao S; Watanabe Y
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():164-7. PubMed ID: 7611782
[TBL] [Abstract][Full Text] [Related]
12. The expression of proliferative-associated nuclear antigen p105 in gastric carcinoma.
Yonemura Y; Ohoyama S; Kimura H; Kamata T; Matsumoto H; Yamaguchi A; Kosaka T; Miwa K; Miyazaki I
Cancer; 1991 May; 67(10):2523-8. PubMed ID: 2015552
[TBL] [Abstract][Full Text] [Related]
13. Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer.
Grabenbauer GG; Steininger H; Meyer M; Fietkau R; Brunner T; Heinkelmann P; Hornung J; Iro H; Spitzer W; Kirchner T; Sauer R; Distel L
Radiother Oncol; 1998 May; 47(2):175-83. PubMed ID: 9683366
[TBL] [Abstract][Full Text] [Related]
14. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
[TBL] [Abstract][Full Text] [Related]
15. Lack of predictive value of potential doubling time and iododeoxyuridine labelling index in radiotherapy of squamous cell carcinoma of the head and neck.
Høyer M; Jørgensen K; Bundgaard T; Johansen LV; Bentzen SM; Overgaard M; Hansen O; Søgaard H; Overgaard J
Radiother Oncol; 1998 Feb; 46(2):147-55. PubMed ID: 9510042
[TBL] [Abstract][Full Text] [Related]
16. DNA flow cytometry in the prediction of survival and response to radiotherapy in head and neck cancer. A review.
Joensuu H
Acta Oncol; 1990; 29(4):513-6. PubMed ID: 2143910
[TBL] [Abstract][Full Text] [Related]
17. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
[TBL] [Abstract][Full Text] [Related]
18. Proliferating cell nuclear antigen and Ki-67 in lung carcinoma. Correlation with DNA flow cytometric analysis.
Kawai T; Suzuki M; Kono S; Shinomiya N; Rokutanda M; Takagi K; Ogata T; Tamai S
Cancer; 1994 Nov; 74(9):2468-75. PubMed ID: 7923002
[TBL] [Abstract][Full Text] [Related]
19. Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.
Nativ O; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
J Urol; 1990 Aug; 144(2 Pt 1):303-6. PubMed ID: 1695690
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
